Curcumin restores D-gal-induced SCs TJ damage <i>in vitro.</i> حسب Chen Xue (699418)

الموضوعات:

D-gal-induced aging led to tight junction damage in SCs <i>in vitro.</i> حسب Chen Xue (699418)

الموضوعات:

Curcumin restores aging-induced disruption of the BTB in mice by activating autophagy in mouse testes injected with D-gal. حسب Chen Xue (699418)

الموضوعات:

LPS induces ferroptosis of lung epithelial cells. حسب Yaping Yuan (2734228)

الموضوعات:

Overexpression of <i>FBLN1</i> can inhibit ferroptosis in LPS-induced ALI. حسب Yaping Yuan (2734228)

الموضوعات:

Schematic diagram of the mechanism by which curcumin ameliorates aging-induced TJ damage in SCs. حسب Chen Xue (699418)

الموضوعات:

D-gal-induced aging leads to reduced autophagy levels in SCs, which are restored by curcumin <i>in vitro.</i> حسب Chen Xue (699418)

الموضوعات:

Flowchart of the study participants. حسب Subeen Kim (11714313)

الموضوعات:

FBLN1 regulates ferroptosis by inhibiting TGF-β. حسب Yaping Yuan (2734228)

الموضوعات:

Characteristics of study participants in women according to frailty groups. حسب Subeen Kim (11714313)

الموضوعات:

Percentage of macronutrient intake relative to the acceptable macronutrient distribution range (AMDR) by frailty groups. حسب Subeen Kim (11714313)

الموضوعات:

Basic characteristics of the study participants by gender. حسب Subeen Kim (11714313)

الموضوعات:

Curcumin restores D-gal-induced SCs TJ injury through autophagy activation <i>in vitro.</i> حسب Chen Xue (699418)

الموضوعات:

Socio-demographic and medical characteristics of patients with liver cancer. حسب Ayana Ablayeva (22103708)

الموضوعات:

Data cleaning and preparation algorithm. حسب Ayana Ablayeva (22103708)

الموضوعات:

A comparison of Paraquat concentrations ^a in various types of plants. حسب Vivat Keawdounglek (9710710)

الموضوعات:

Purposive Sampling of Traditional Lanna Restaurants. حسب Vivat Keawdounglek (9710710)

الموضوعات:

CONSORT of participants with OPV status. حسب Zahid Hasan Khan (6281396)

الموضوعات:

Crude and age-specific incidence rates (A), all-cause mortality rates (B), and prevalence rates (C) of liver cancer per 100,000 over 2014–2023. حسب Ayana Ablayeva (22103708)

الموضوعات:

Laab Nuer^a. ^a Photographed by Vivat Keawdounglek. حسب Vivat Keawdounglek (9710710)

الموضوعات: